We are live on ! Find out more
SC

Schiavi & Co Portfolio holdings

AUM $337M
1-Year Est. Return 16.69%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+16.69%
3 Year Est. Return
+32.96%
5 Year Est. Return
+28.88%
10 Year Est. Return
AUM
$231M
AUM Growth
+$73.5M
Cap. Flow
+$66.3M
Cap. Flow %
28.71%
Top 10 Hldgs %
98.02%
Holding
22
New
3
Increased
9
Reduced
4
Closed
1
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFDX icon
1
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$448M
$87.5M 37.88%
3,171,776
+542,193
+21% +$14.7M
MFUS icon
2
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$292M
$53.4M 23.14%
1,396,198
+102,714
+8% +$3.97M
VGSH icon
3
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$24.7M 10.72%
422,693
+411,994
+3,851% +$23.9M
MFEM icon
4
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$137M
$17.6M 7.64%
973,718
+333,126
+52% +$6.05M
IVOL icon
5
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$274M
$16.4M 7.11%
722,760
+280,978
+64% +$6.2M
BIV icon
6
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$15M 6.5%
195,489
+125,556
+180% +$9.51M
VTEB icon
7
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$6.45M 2.79%
127,339
+27,378
+27% +$1.37M
AGG icon
8
iShares Core US Aggregate Bond ETF
AGG
$138B
$2.34M 1.01%
23,520
-4,694
-17% -$464K
IEFA icon
9
iShares Core MSCI EAFE ETF
IEFA
$186B
$2.01M 0.87%
30,060
-691
-2% -$45.3K
AAPL icon
10
Apple
AAPL
$4.97T
$821K 0.36%
4,981
-25
-0.5% -$3.69K
AZN icon
11
AstraZeneca
AZN
$269B
$796K 0.34%
+5,736
New +$772K
BSV icon
12
Vanguard Short-Term Bond ETF
BSV
$44.7B
$730K 0.32%
9,544
JNJ icon
13
Johnson & Johnson
JNJ
$640B
$461K 0.2%
2,971
JPEM icon
14
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$382M
$451K 0.2%
8,933
+58
+0.7% +$2.94K
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.1T
$441K 0.19%
1,428
ITOT icon
16
iShares Core S&P Total US Stock Market ETF
ITOT
$92.3B
$401K 0.17%
4,430
VTI icon
17
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$396K 0.17%
1,942
+552
+40% +$111K
JPM icon
18
JPMorgan Chase
JPM
$916B
$247K 0.11%
+1,897
New +$260K
XOM icon
19
ExxonMobil
XOM
$650B
$242K 0.1%
2,204
-68
-3% -$7.52K
DD icon
20
DuPont de Nemours
DD
$18.6B
$230K 0.1%
+2,552
New +$233K
SSP icon
21
E.W. Scripps
SSP
$270M
$170K 0.07%
18,087
VCSH icon
22
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
-3,305
Closed -$249K

Similar funds

Schiavi & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Schiavi & Co held 22 positions worth $231M, up 47% from $157M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Schiavi & Co deployed $66.3M of net new capital in Q1 2023, opening 3 new positions and adding to 9 existing holdings. Its largest new stake was AstraZeneca: 5,736 shares worth $796K.

By sector, the portfolio is most concentrated in Healthcare at 0.54% of assets, up from 0.33% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $464K trimmed.

  • Schiavi & Co's largest Q1 2023 buy was AstraZeneca: 5,736 shares worth $796K.
  • Schiavi & Co added most to Vanguard Short-Term Treasury ETF in Q1 2023, an estimated $23.9M increase.
  • Schiavi & Co's biggest Q1 2023 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $464K.
  • Schiavi & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q1 2023, selling an estimated $249K.
  • Schiavi & Co's ten largest holdings make up 98% of its $231M portfolio in Q1 2023.
  • Schiavi & Co opened 3 new positions and closed 1 in Q1 2023.
  • Schiavi & Co's portfolio value rose 47% quarter-over-quarter to $231M.

Based on Schiavi & Co's 13F filing for Q1 2023, filed 3 May 2023.